These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1965141)

  • 21. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.
    Weinstein DL; Jackson MP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1988 Sep; 170(9):4223-30. PubMed ID: 3045088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
    Waddell T; Head S; Petric M; Cohen A; Lingwood C
    Biochem Biophys Res Commun; 1988 Apr; 152(2):674-9. PubMed ID: 3284526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms.
    Van Setten PA; van Hinsbergh VW; Van den Heuvel LP; van der Velden TJ; van de Kar NC; Krebbers RJ; Karmali MA; Monnens LA
    J Am Soc Nephrol; 1997 Dec; 8(12):1877-88. PubMed ID: 9402090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis.
    Maloney MD; Lingwood CA
    J Exp Med; 1994 Jul; 180(1):191-201. PubMed ID: 7516406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines.
    Ramegowda B; Tesh VL
    Infect Immun; 1996 Apr; 64(4):1173-80. PubMed ID: 8606075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
    Tesh VL; Samuel JE; Perera LP; Sharefkin JB; O'Brien AD
    J Infect Dis; 1991 Aug; 164(2):344-52. PubMed ID: 1649877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor.
    Ashkenazi S; Cleary TG
    J Clin Microbiol; 1989 Jun; 27(6):1145-50. PubMed ID: 2666433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e.
    Keusch GT; Jacewicz M; Acheson DW; Donohue-Rolfe A; Kane AV; McCluer RH
    Infect Immun; 1995 Mar; 63(3):1138-41. PubMed ID: 7868240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3.
    Ling H; Boodhoo A; Hazes B; Cummings MD; Armstrong GD; Brunton JL; Read RJ
    Biochemistry; 1998 Feb; 37(7):1777-88. PubMed ID: 9485303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E. coli scare spawns therapy search.
    Service RF
    Science; 1994 Jul; 265(5171):475. PubMed ID: 8036490
    [No Abstract]   [Full Text] [Related]  

  • 31. Verotoxins and their glycolipid receptors.
    Lingwood CA
    Adv Lipid Res; 1993; 25():189-211. PubMed ID: 8368148
    [No Abstract]   [Full Text] [Related]  

  • 32. Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis.
    Jackson MP; Wadolkowski EA; Weinstein DL; Holmes RK; O'Brien AD
    J Bacteriol; 1990 Feb; 172(2):653-8. PubMed ID: 2404947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II.
    Wadolkowski EA; Sung LM; Burris JA; Samuel JE; O'Brien AD
    Infect Immun; 1990 Dec; 58(12):3959-65. PubMed ID: 2254023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro assessment of a chemically synthesized Shiga toxin receptor analog attached to chromosorb P (Synsorb Pk) as a specific absorbing agent of Shiga toxin 1 and 2.
    Takeda T; Yoshino K; Adachi E; Sato Y; Yamagata K
    Microbiol Immunol; 1999; 43(4):331-7. PubMed ID: 10385199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shiga-like toxin production and attaching effacing activity of Escherichia coli associated with calf diarrhea.
    Mainil JG; Duchesnes CJ; Whipp SC; Marques LR; O'Brien AD; Casey TA; Moon HW
    Am J Vet Res; 1987 May; 48(5):743-8. PubMed ID: 3296889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1.
    Sandvig K; Olsnes S; Brown JE; Petersen OW; van Deurs B
    J Cell Biol; 1989 Apr; 108(4):1331-43. PubMed ID: 2564398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of infections with Shiga-like toxin-producing Escherichia coli by use of enzyme-linked immunosorbent assays for Shiga-like toxins on cultured stool samples.
    Law D; Hamour AA; Acheson DW; Panigrahi H; Ganguli LA; Denning DW
    J Med Microbiol; 1994 Apr; 40(4):241-5. PubMed ID: 8151673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycolipid modification of alpha 2 interferon binding. Sequence similarity between the alpha 2 interferon receptor and verotoxin (Shiga-like toxin) B-subunit.
    Lingwood CA; Yiu SK
    Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):25-6. PubMed ID: 1314564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of verotoxin receptors in nervous system.
    Ren J; Utsunomiya I; Taguchi K; Ariga T; Tai T; Ihara Y; Miyatake T
    Brain Res; 1999 Apr; 825(1-2):183-8. PubMed ID: 10216186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One step high yield affinity purification of shiga-like toxin II variants and quantitation using enzyme linked immunosorbent assays.
    Acheson DW; Jacewicz M; Kane AV; Donohue-Rolfe A; Keusch GT
    Microb Pathog; 1993 Jan; 14(1):57-66. PubMed ID: 8321118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.